This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) encompasses analytics across advances in targeted neurological therapies, cancer treatments, and AI-powered drug development. The TOE also features innovators for the treatment of metabolic diseases such as obesity and heart failure.

• What are the disruptive technological advances in the global life sciences industry?
• Which growth prospects will redefine the future of genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, and disease management?
• How can your team harness key technologies, innovations, and developments across the health and wellness landscape and achieve exponential growth?